Friday, April 19, 2024 4/19/2024

Developing strategies for effective debridement in patients for venous leg ulcers

Award Number: R01AR073614
ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

Project Summary The goal of this research is to use gene and protein expression patterns to develop point of care diagnostic tool that can serve as a guiding tool to optimize debridement for non-healing venous leg ulcers (VLUs). Thus, it will identify objective and reliable biomarkers that will guide wound practitioners to make informed decision when wound edge debridement is adequate. We have shown that biopsies obtained from the non- healing edges of VLUs before/after debridement have distinct morphologies and distinguishable gene and protein expression patterns. Cells generated from pre-debridement edge biopsies exhibit a non-healing phenotype as evidenced by loss of migration and loss of ability to respond to growth factors, suggesting a loss of healing potential whereas cells genrated from post-debridement biopsy are migratiory and responsive to growth factors. Some clinical data show a positive response in VLUs wound size reduction following wound bed debridemet. However, wound bed debridement is not always considered standard of care for VLUs. Therefore we aim to compare effectivnes of two therapeutic approaches: standard of care (i.e. compression therapy) and wound bed debridement coupled to standard of care. The intervention arm will consit of two subgroups, a) one that utilizes gene/protein expression-guidaded debridement protocol, and b) uses standard clinical debridement protocol for VLUs. We hypothesize that gene/protein expression patterns can be utilized to guide wound edge debridement in VLUs and further that such biomarker-guided debridement will improve healing outcome in patients suffering from chronic non-healing VLUs. Also, based on genomic profiles we plan to develop specific PCR- and immunostain-based methods to serve as a simplified diagnostic test to guide the extent of debridment. Thus, we will conduct a randomized clinical trial to test if gene expression patterns can be utilized as a guiding tool for the debridement extent and to test the effect of wound edge debridement on healing progression (Aim 1) and develop PCR- and/or immunostain-based complementary assessment method and validate it for guiding surgical debridement (Aim 2). We will proceed with genomic profiling and compare gene expression patterns of specimens obtained before and after debridement. Next, expression patterns will be correlated with healing outcomes comparing patients with wounds that progressed to healing with those that did not at 4 weeks post intervention. The proposed study is the first step in incorporating gene/protein wound signatures as a clinical tool. Successful completion of this study will provide objective biological markers to guide wound edge debridement in patients suffering from VLUs. Incorporation of molecular tools into armory of intervention will result in a paradigm shift that will alter the course of healing, decrease morbidity, mortality, and lower associated treatment costs.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2023	UNIVERSITY OF MIAMI	1320 S DIXIE HWY STE 1200	CORAL GABLES	FL	33146	MIAMI-DADE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	5	1/3/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $472,517 )
2023	2023	UNIVERSITY OF MIAMI	1600 NW 10 AVE	MIAMI	FL	33136	MIAMI-DADE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	5	12/22/2022	NON-COMPETING CONTINUATION	$425,266
2023	2023	UNIVERSITY OF MIAMI	1400 NW 10TH AVE	MIAMI	FL	33136	MIAMI-DADE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	001	5	2/22/2023	NON-COMPETING CONTINUATION	$47,251
														Subtotal = $472,517

Issue Date FY: 2022 ( Subtotal = $534,702 )
2022	2022	UNIVERSITY OF MIAMI	1600 NW 10 AVE	MIAMI	FL	33136	MIAMI-DADE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	002	4	9/12/2022	NON-COMPETING CONTINUATION	$48,608
2022	2022	UNIVERSITY OF MIAMI	1600 NW 10 AVE	MIAMI	FL	33136	MIAMI-DADE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	001	4	3/28/2022	NON-COMPETING CONTINUATION	$0
2022	2022	UNIVERSITY OF MIAMI	1600 NW 10 AVE	MIAMI	FL	33136	MIAMI-DADE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	4	11/22/2021	NON-COMPETING CONTINUATION	$486,094
														Subtotal = $534,702

Issue Date FY: 2021 ( Subtotal = $523,900 )
2021	2021	UNIVERSITY OF MIAMI	1600 NW 10 AVE	MIAMI	FL	33136	MIAMI-DADE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	001	3	5/17/2021	NON-COMPETING CONTINUATION	$37,806
2021	2021	UNIVERSITY OF MIAMI	1600 NW 10 AVE	MIAMI	FL	33136	MIAMI-DADE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	3	12/2/2020	NON-COMPETING CONTINUATION	$486,094
														Subtotal = $523,900

Issue Date FY: 2020 ( Subtotal = $530,649 )
2020	2020	UNIVERSITY OF MIAMI	1600 NW 10 AVE	MIAMI	FL	33136	MIAMI-DADE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	002	2	7/29/2020	NON-COMPETING CONTINUATION	$0
2020	2020	UNIVERSITY OF MIAMI	1600 NW 10 AVE	MIAMI	FL	33136	MIAMI-DADE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	001	2	4/14/2020	NON-COMPETING CONTINUATION	$53,065
2020	2020	UNIVERSITY OF MIAMI	1600 NW 10 AVE	MIAMI	FL	33136	MIAMI-DADE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	2	12/16/2019	NON-COMPETING CONTINUATION	$477,584
														Subtotal = $530,649

Issue Date FY: 2019 ( Subtotal = $0 )
2019	2018	UNIVERSITY OF MIAMI	1600 NW 10 AVE	MIAMI	FL	33136	MIAMI-DADE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	1	5/21/2019	NEW	$0
														Subtotal = $0

Issue Date FY: 2018 ( Subtotal = $565,514 )
2018	2018	UNIVERSITY OF MIAMI	1600 NW 10 AVE	MIAMI	FL	33136	MIAMI-DADE	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	1	8/29/2018	NEW	$565,514
														Subtotal = $565,514

Grand Total All Awards = $2,627,282

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Developing strategies for effective debridement in patients for venous leg ulcers

Award Number: R01AR073614

ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer